For the majority of vaccines in the UK childhood vaccine cohort (up to five years), coverage decreased slightly in the first quarter (Q1) of 2018, according to the latest surveillance data from Public Health England (PHE).
UK vaccine coverage evaluated at 12 months decreased by at least 0.5 per cent this quarter for all vaccines (except rotavirus) offered in the first year of life, compared to the last quarter of 2017. These are the lowest quarterly figures recorded for DTaP/IPV/Hib3 (93.1%) and PCV2 (93.3%) since the April to June 2009 quarter.
MenB booster coverage at 24 months of age increased 0.4 per cent to 88.8 per cent. However, UK coverage of all other vaccines evaluated at 24 months decreased between 0.1 per cent and 0.2 per cent.
Pre-school DTaP/IPV and Hib/MenC booster coverage declined by 0.5 per cent and 0.2 per cent to 86.4 per cent and 93 per cent, respectively, and MMR2 coverage declined by 0.3 per cent to 87.7 per cent.
However, UK coverage of DTaP/IPV/Hib3 and MMR1 at five years continued to exceed the 95 per cent World Health Organization (WHO) target, at 95.8 per cent and 95.3 per cent, respectively, in Q1 according to the report.
